EP3261676 - LIQUID LEVOTHYROXINE FORMULATIONS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 23.04.2021 Database last updated on 02.08.2024 | |
Former | The patent has been granted Status updated on 15.05.2020 | ||
Former | Grant of patent is intended Status updated on 01.12.2019 | ||
Former | Request for examination was made Status updated on 01.12.2017 | ||
Former | The international publication has been made Status updated on 04.11.2016 | Most recent event Tooltip | 27.04.2024 | Lapse of the patent in a contracting state New state(s): MK | published on 29.05.2024 [2024/22] | Applicant(s) | For all designated states TAP Pharmaceuticals AG Neuhofstrasse 5A, 5th Floor 6340 Baar / CH | [N/P] |
Former [2020/24] | For all designated states TAP Pharmaceuticals AG Neuhofstrasse 5A, 5h Floor 6340 Baar / CH | ||
Former [2018/01] | For all designated states Parikh, Nilesh 1672 Railroad Street Corona, CA 92880 / US | ||
For all designated states Hite, William 1672 Railroad Street Corona, CA 92880 / US | Inventor(s) | 01 /
PARIKH, Nilesh 1672 Railroad Street Corona, CA 92880 / US | 02 /
HITE, William 1672 Railroad Street Corona, CA 92880 / US | [2020/25] |
Former [2018/01] | 01 /
see applicant ... | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [2018/01] | Application number, filing date | 16756169.5 | 23.02.2016 | [2018/01] | WO2016US19093 | Priority number, date | US201514634452 | 27.02.2015 Original published format: US201514634452 | [2018/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2016137969 | Date: | 01.09.2016 | Language: | EN | [2016/35] | Type: | A2 Application without search report | No.: | EP3261676 | Date: | 03.01.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.09.2016 takes the place of the publication of the European patent application. | [2018/01] | Type: | B1 Patent specification | No.: | EP3261676 | Date: | 17.06.2020 | Language: | EN | [2020/25] | Search report(s) | International search report - published on: | US | 03.11.2016 | (Supplementary) European search report - dispatched on: | EP | 13.09.2018 | Classification | IPC: | A61K9/08, A61K47/18, A61K31/198, A61K47/10, A61K9/00 | [2018/42] | CPC: |
A61K47/183 (EP,US);
A61K31/198 (EP,US);
A61K47/10 (EP,US);
A61K9/08 (EP,US);
A61K9/0095 (EP,US)
|
Former IPC [2018/01] | A61K47/18, A61K31/198 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/01] | Extension states | BA | 25.09.2017 | ME | 25.09.2017 | Validation states | MA | 25.09.2017 | MD | 25.09.2017 | Title | German: | FLÜSSIGE LEVOTHYROXINFORMULIERUNGEN | [2018/01] | English: | LIQUID LEVOTHYROXINE FORMULATIONS | [2018/01] | French: | FORMULATIONS LIQUIDES DE LÉVOTHYROXINE | [2018/01] | Entry into regional phase | 25.09.2017 | National basic fee paid | 25.09.2017 | Search fee paid | 25.09.2017 | Designation fee(s) paid | 25.09.2017 | Examination fee paid | Examination procedure | 25.09.2017 | Examination requested [2018/01] | 25.09.2017 | Date on which the examining division has become responsible | 04.04.2019 | Amendment by applicant (claims and/or description) | 02.12.2019 | Communication of intention to grant the patent | 30.04.2020 | Fee for grant paid | 30.04.2020 | Fee for publishing/printing paid | 30.04.2020 | Receipt of the translation of the claim(s) | Opposition(s) | 18.03.2021 | No opposition filed within time limit [2021/21] | Fees paid | Renewal fee | 23.02.2018 | Renewal fee patent year 03 | 21.02.2019 | Renewal fee patent year 04 | 20.02.2020 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 17.06.2020 | CY | 17.06.2020 | DK | 17.06.2020 | EE | 17.06.2020 | FI | 17.06.2020 | LT | 17.06.2020 | LV | 17.06.2020 | MC | 17.06.2020 | MK | 17.06.2020 | RS | 17.06.2020 | SK | 17.06.2020 | SM | 17.06.2020 | NO | 17.09.2020 | IS | 17.10.2020 | PT | 19.10.2020 | LU | 23.02.2021 | BE | 28.02.2021 | [2024/22] |
Former [2023/30] | AT | 17.06.2020 | |
CY | 17.06.2020 | ||
DK | 17.06.2020 | ||
EE | 17.06.2020 | ||
FI | 17.06.2020 | ||
LT | 17.06.2020 | ||
LV | 17.06.2020 | ||
MC | 17.06.2020 | ||
RS | 17.06.2020 | ||
SK | 17.06.2020 | ||
SM | 17.06.2020 | ||
NO | 17.09.2020 | ||
IS | 17.10.2020 | ||
PT | 19.10.2020 | ||
LU | 23.02.2021 | ||
BE | 28.02.2021 | ||
Former [2022/33] | AT | 17.06.2020 | |
DK | 17.06.2020 | ||
EE | 17.06.2020 | ||
FI | 17.06.2020 | ||
LT | 17.06.2020 | ||
LV | 17.06.2020 | ||
MC | 17.06.2020 | ||
RS | 17.06.2020 | ||
SK | 17.06.2020 | ||
SM | 17.06.2020 | ||
NO | 17.09.2020 | ||
IS | 17.10.2020 | ||
PT | 19.10.2020 | ||
LU | 23.02.2021 | ||
BE | 28.02.2021 | ||
Former [2022/07] | AT | 17.06.2020 | |
DK | 17.06.2020 | ||
EE | 17.06.2020 | ||
FI | 17.06.2020 | ||
LT | 17.06.2020 | ||
LV | 17.06.2020 | ||
MC | 17.06.2020 | ||
RS | 17.06.2020 | ||
SK | 17.06.2020 | ||
SM | 17.06.2020 | ||
NO | 17.09.2020 | ||
IS | 17.10.2020 | ||
PT | 19.10.2020 | ||
LU | 23.02.2021 | ||
Former [2021/47] | AL | 17.06.2020 | |
AT | 17.06.2020 | ||
DK | 17.06.2020 | ||
EE | 17.06.2020 | ||
FI | 17.06.2020 | ||
LT | 17.06.2020 | ||
LV | 17.06.2020 | ||
MC | 17.06.2020 | ||
RS | 17.06.2020 | ||
SK | 17.06.2020 | ||
SM | 17.06.2020 | ||
NO | 17.09.2020 | ||
IS | 17.10.2020 | ||
PT | 19.10.2020 | ||
LU | 23.02.2021 | ||
Former [2021/41] | AL | 17.06.2020 | |
AT | 17.06.2020 | ||
DK | 17.06.2020 | ||
EE | 17.06.2020 | ||
FI | 17.06.2020 | ||
LT | 17.06.2020 | ||
LV | 17.06.2020 | ||
MC | 17.06.2020 | ||
RS | 17.06.2020 | ||
SK | 17.06.2020 | ||
SM | 17.06.2020 | ||
NO | 17.09.2020 | ||
IS | 17.10.2020 | ||
PT | 19.10.2020 | ||
Former [2021/21] | AL | 17.06.2020 | |
AT | 17.06.2020 | ||
DK | 17.06.2020 | ||
EE | 17.06.2020 | ||
FI | 17.06.2020 | ||
LT | 17.06.2020 | ||
LV | 17.06.2020 | ||
RS | 17.06.2020 | ||
SK | 17.06.2020 | ||
SM | 17.06.2020 | ||
NO | 17.09.2020 | ||
IS | 17.10.2020 | ||
PT | 19.10.2020 | ||
Former [2021/11] | AL | 17.06.2020 | |
AT | 17.06.2020 | ||
EE | 17.06.2020 | ||
FI | 17.06.2020 | ||
LT | 17.06.2020 | ||
LV | 17.06.2020 | ||
RS | 17.06.2020 | ||
SK | 17.06.2020 | ||
SM | 17.06.2020 | ||
NO | 17.09.2020 | ||
IS | 17.10.2020 | ||
PT | 19.10.2020 | ||
Former [2021/09] | AL | 17.06.2020 | |
AT | 17.06.2020 | ||
EE | 17.06.2020 | ||
FI | 17.06.2020 | ||
LT | 17.06.2020 | ||
LV | 17.06.2020 | ||
RS | 17.06.2020 | ||
SM | 17.06.2020 | ||
NO | 17.09.2020 | ||
PT | 19.10.2020 | ||
Former [2021/04] | AL | 17.06.2020 | |
FI | 17.06.2020 | ||
LT | 17.06.2020 | ||
LV | 17.06.2020 | ||
RS | 17.06.2020 | ||
NO | 17.09.2020 | ||
Former [2020/51] | FI | 17.06.2020 | |
LT | 17.06.2020 | ||
LV | 17.06.2020 | ||
RS | 17.06.2020 | ||
NO | 17.09.2020 | ||
Former [2020/48] | FI | 17.06.2020 | |
LT | 17.06.2020 | ||
NO | 17.09.2020 | ||
Former [2020/47] | LT | 17.06.2020 | |
NO | 17.09.2020 | Documents cited: | Search | [ID]WO9520955 (BOOTS CO PLC [GB], et al) [ID] 1-15* examples 2,3; claim 1 * | International search | [Y]US5951989 (HEYMANN WARREN R [US]) [Y] 1-19* , SEE ENTIRE DOCUMENT. *; | [X]US2014073695 (PSARRAKIS YANNIS [GR], et al) [X] 1-19 * , SEE ENTIRE DOCUMENT. * |